LBS-007

· Lin BioScience, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LBS-007, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias [Phase 1, Phase 2]